(Q72769559)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

title

Urinary trypsin inhibitor (UTI) and fragments derived from UTI by limited proteolysis efficiently inhibit tumor cell invasion (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference

urinary tract infection

1 reference

H Kobayashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H Shinohara

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

H Ohi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M Sugimura

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

T Terao

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

M Fujie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

publication date

1 March 1994

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

Clinical & Experimental Metastasis

29 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

page(s)

117-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf01753978

29 October 2019

exact match

0 references

cites work

Fibronectin: purification, immunochemical properties, and biological activities

1 reference

12 December 2020

Structure of inter-alpha-inhibitor (inter-alpha-trypsin inhibitor) and pre-alpha-inhibitor: current state and proposition of a new terminology

1 reference

12 December 2020

[Cytotoxicity of T-lymphocytes from a patient with choriocarcinoma to autologous tumor cultured cells--stimulation with the husband's lymphocytes]

1 reference

12 December 2020

Autocrine saturation of pro-urokinase receptors on human A431 cells.

1 reference

12 December 2020

Elastase inhibition by the inter-alpha-trypsin inhibitor and derived inhibitors of man and cattle

1 reference

12 December 2020

Basement membrane and the invasive activity of metastatic tumor cells

1 reference

12 December 2020

A proteoglycan related to the urinary trypsin inhibitor (UTI) links the two heavy chains of inter-alpha-trypsin inhibitor

1 reference

12 December 2020

Tissue plasminogen activator and urokinase in normal, dysplastic and cancerous squamous epithelium of the uterine cervix

1 reference

12 December 2020

Kunitz-Type Proteinase Inhibitors Derived by Limited Proteolysis of the Inter-α-Trypsin Inhibitor, VIII. Characterization of the Bovine Inhibitor as Double-Headed Tiypsin-Elastase Inhibitor

1 reference

12 December 2020

Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials

1 reference

12 December 2020

Mouse L cells expressing human prourokinase-type plasminogen activator: effects on extracellular matrix degradation and invasion

1 reference

12 December 2020

Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA)

1 reference

12 December 2020

Tumor invasion through the human amniotic membrane: requirement for a proteinase cascade

1 reference

12 December 2020

Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro.

1 reference

12 December 2020

Receptor for plasmin on human carcinoma cells

1 reference

12 December 2020

Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase-type plasminogen activator and cathepsin B

1 reference

12 December 2020

Plasma proteins immunologically related to inter-alpha-trypsin inhibitor.

1 reference

12 December 2020

Modulation of metastatic potential by cell surface urokinase of murine melanoma cells

1 reference

12 December 2020

Inhibitory effect of human urinary trypsin inhibitor (urinastatin) on lysosomal thiol proteinases

1 reference

12 December 2020

Kunitz-Type Proteinase Inhibitors Derived by Limited Proteolysis of the Inter-α-Trypsin Inhibitor, IV. The Amino Acid Sequence of the Human Urinary Trypsin Inhibitor Isolated by Affinity Chromatography

1 reference

12 December 2020

Effects of inhibitors of plasminogen activator, serine proteinases, and collagenase IV on the invasion of basement membranes by metastatic cells.

1 reference

12 December 2020

Membrane invasion culture system (MICS)

1 reference

12 December 2020

Kunitz-Type Proteinase Inhibitors Derived by Limited Proteolysis of the Inter-α-Trypsin Inhibitor, V[1–4]. Attachments of Carbohydrates in the Human Urinary Trypsin Inhibitor Isolated by Affinity Chromatography

1 reference

12 December 2020

The use of avidin-biotin interaction in immunoenzymatic techniques

1 reference

12 December 2020

Identification and characterization of the murine cell surface receptor for the urokinase-type plasminogen activator

1 reference

12 December 2020

Inhibition of cancer cell urokinase plasminogen activator by its specific inhibitor PAI-2 and subsequent effects on extracellular matrix degradation

1 reference

12 December 2020

Human inter-alpha-trypsin inhibitor: localization of the Kunitz-type domains in the N-terminal part of the molecule and their release by a trypsin-like proteinase

1 reference

12 December 2020

Radioimmunological quantitation of the urinary trypsin inhibitor in normal blood and urine

1 reference

12 December 2020

Inhibition of receptor-bound urokinase by plasminogen-activator inhibitors

1 reference

12 December 2020

A rapid in vitro assay for quantitating the invasive potential of tumor cells

1 reference

12 December 2020

Establishment and characterization of human ovarian endometrioid carcinoma cell line

1 reference

12 December 2020

Characterization of the cellular binding site for the urokinase-type plasminogen activator

1 reference

12 December 2020

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

1 reference

12 December 2020

Plasminogen activators, tissue degradation, and cancer

1 reference

12 December 2020

Elastase released from human granulocytes stimulated with N-formyl-chemotactic peptide prevents activation of tumor cell prourokinase (pro-uPA)

1 reference

12 December 2020

Basement membrane complexes with biological activity

1 reference

12 December 2020

Metastatic potential correlates with enzymatic degradation of basement membrane collagen

1 reference

12 December 2020

Differential detection of single-chain and two-chain urokinase-type plasminogen activator by a new immunoadsorbent-amidolytic assay (IAA)

1 reference

12 December 2020

Tumor invasion and the extracellular matrix

1 reference

12 December 2020

Invasion of reconstituted basement membrane matrix is not correlated to the malignant metastatic cell phenotype

1 reference

12 December 2020

Cell membrane receptors for urokinase plasminogen activator are increased in malignant ovarian tumours

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF01753978

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8306525%20AND%20SRC:MED&resulttype=core&format=json

29 October 2019

1 reference